(WLY) John Wiley & Sons - Ratings and Ratios

John Wiley & Sons, Inc. (NYSE: WLY) is a global leader in research and education, operating through three primary segments: Research, Learning, and Held for Sale or Sold. Established in 1807, Wiley is renowned for its extensive portfolio of scientific, technical, medical, and scholarly journals, as well as its digital learning solutions. The company serves a diverse clientele, including academic institutions, research libraries, corporations, and individual professionals, offering content and services that span physical sciences, health sciences, social sciences, and humanities. Wileys Literatum platform provides comprehensive publishing support, from submissions and peer review to content hosting. Additionally, Wiley delivers academic and professional books, digital courseware, and online learning solutions, enhancing access to knowledge and skills for students, professionals, and organizations worldwide. Headquartered in Hoboken, New Jersey, Wiley has evolved from a traditional publisher to a dynamic provider of digital education and training solutions, addressing the needs of a global audience.

Based on the provided data, the 3-month forecast for John Wiley & Sons, Inc. (NYSE: WLY) suggests cautious optimism. Technically, the stock is trading near its SMA200 level of 44.93, with a last price of 44.14, indicating potential resistance. The SMA20 (42.75) and SMA50 (42.42) suggest a neutral to slightly bearish short-term outlook. The ATR of 1.28 indicates moderate volatility. Fundamentally, the companys high P/E ratio of 58.88, compared to a forward P/E of 10.83, points to expected earnings growth. However, the ROE of 6.03% is relatively low, and the P/B ratio of 3.42 suggests a premium valuation. Considering these factors, the stock may experience sideways movement or a slight decline in the near term, with potential upside if earnings expectations are met.